Redo-Transcatheter Aortic Valve Replacement: Strategies When the First Transcatheter Aortic Valve Replacement Fails
Transcatheter aortic valve replacement (TAVR) is the standard of care for patients with symptomatic severe aortic stenosis at high or prohibitive surgical risk. The 2020 valvular heart disease guidelines from the American College of Cardiology and American Heart Association now include TAVR as a cla...
Main Authors: | Nils Perrin, Anita W Asgar |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2022-03-01
|
Series: | US Cardiology Review |
Online Access: | https://www.uscjournal.com/articleindex/usc.2021.18 |
Similar Items
-
Valve‐in‐Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement for Failed Surgical Aortic Bioprostheses: A Systematic Review and Meta‐Analysis
by: Matthias Raschpichler, et al.
Published: (2022-12-01) -
Transcatheter aortic valve replacement valve in transcatheter aortic valve replacement valve for severe periprosthetic regurgitation
by: Sneha Nandy, et al.
Published: (2020-01-01) -
Hemodynamic and Clinical Outcomes in Redo-Surgical Aortic Valve Replacement vs. Transcatheter Valve-in-Valve
by: Sébastien Hecht, MSc, et al.
Published: (2022-11-01) -
Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era
by: Luca Testa, et al.
Published: (2019-11-01) -
Editorial: Minding the Gradient — Valve-in-Valve Transcatheter Aortic Valve Replacement vs. Redo Surgical Aortic Valve Replacements for Surgical Bioprosthetic Valve Failure
by: Syed Zaid, MD, et al.
Published: (2022-11-01)